论文部分内容阅读
目的探讨新诊断原发性高血压(EH)与胰岛素抵抗及糖脂代谢异常的相关性,以期临床上予以关注,进行适当的早期干预治疗。方法将62例EH分Ⅰ级EH组和Ⅱ级EH组,根据空腹血糖、胰岛素、HOHA-IR、ISI及TC、TG分别进行此两组间及对照组比较。结果Ⅱ级EH组FPG、FINS、HOMA-IR增加均大于Ⅰ级EH组及对照组(P<0.01)。ISI:Ⅱ级EH组小于Ⅰ级EH组和对照组(P<0.05)。Ⅰ级EH组中IFG发生率为78.1%;Ⅱ级EH组中IFG发生率为43.3%,DM发生率为56.7%。Ⅰ级EH组中高TC、高TG发生率分别为31.3%和37.5%,Ⅱ级EH组中高TC、高TG发生率分别为53.3%和63.3%(组间分别比较均P<0.01)。结论新诊断原发性高血压与胰岛素抵抗及糖脂代谢异常有相关性,Ⅱ级EH组较Ⅰ级EH组显著。
Objective To investigate the relationship between newly diagnosed essential hypertension (EH) and insulin resistance and abnormal glucose and lipid metabolism, so as to pay close attention to the clinical and make appropriate early intervention. Methods Sixty-two EH patients were divided into two groups according to fasting blood glucose, insulin, HOHA-IR, ISI, TC and TG. Results The levels of FPG, FINS and HOMA-IR in grade Ⅱ EH group were significantly higher than those in grade Ⅰ EH group and control group (P <0.01). ISI: Grade II EH group was less than Grade I EH group and control group (P <0.05). The incidence of IFG in grade I EH was 78.1%, that in grade II EH was 43.3%, and that of DM was 56.7%. The incidences of high TC and high TG in stage Ⅰ EH were 31.3% and 37.5%, respectively. The incidences of high TC and high TG in stage Ⅱ EH were 53.3% and 63.3%, respectively (all P <0.01, respectively). Conclusions There is a correlation between newly diagnosed essential hypertension and insulin resistance and abnormal glucose and lipid metabolism. Grade Ⅱ EH is more obvious than grade Ⅰ EH.